Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article December 4 2025
Belantamab mafodotin, lenalidomide and dexamethasone (BelaRd) in newly diagnosed intermediate-fit and frail myeloma
Research Article December 4 2025
Lipid nanotubes unmask neutrophils for complement attack
Review Article December 2 2025
How I Treat Advanced Phases of CML
Research Article December 1 2025
NLRP3 inflammasome blockade treats intestinal inflammation associated with chronic granulomatous disease.
Review Article November 25 2025
Prostaglandins in cancer revisited: principles of production, mechanisms of immune regulation, and therapeutic perspectives
Review Article November 25 2025
Hemophagocytic Lymphohistiocytosis in Adults
Letter November 25 2025
Somatic genetic rescue in ZCCHC8-associated telomere biology disorders
Research Article November 25 2025
Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to Cyclosporine
Research Article November 24 2025
­IFN-γ increases δ-globin gene expression through activation of the JAK/STAT pathway in erythroid cells
Letter November 24 2025
Prior transplantation and idecabtagene vicleucel in multiple myeloma: a secondary analysis of CIBMTR data
Research Article November 24 2025
Multisite Validation of a Venous Thrombosis Risk Model in Critically Ill Children Through the CHAT Consortium
Research Article November 24 2025
Platelet defects in patients and mice with Ehlers-Danlos syndrome
Research Article November 21 2025
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study
Research Article November 19 2025
Outcome of children with B-cell acute lymphoblastic leukemia with hypodiploidy or BCR::ABL1 fusion undergoing allogeneic HSCT
Research Article November 14 2025
Integrin αvβ8-mediated TGF-β1 activation regulates sustained response in immune thrombocytopenia after TPO-RA withdrawal
Research Article November 14 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18
Research Article November 14 2025
Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation
Research Article November 14 2025
Highly discriminative globin gene activation by the non-canonical BAF chromatin remodeling complex
Letter November 10 2025
Utility of Peripheral Blood Testing for Detection and Surveillance of Clonal Hematopoiesis in Predisposed Individuals (CH-IPI)
Research Article November 10 2025
Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemia
Research Article November 6 2025
Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy
Research Article November 5 2025
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy
Research Article November 5 2025
Dynamic rRNA Methylation Regulates Translation in the Hematopoietic System and is Essential for Stem Cell Fitness
Research Article November 5 2025
Multinational Assessment of Absolute Neutrophil Counts and White Blood Cell Counts Among Healthy Duffy Null Adults
Research Article November 5 2025
PIKfyve inhibition in myeloma disrupts autophagy and the lysosome, increasing MHC expression and cholesterol metabolism
Research Article November 5 2025
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells
Research Article November 5 2025
Silencing of BCL11A by Disrupting Enhancer-Dependent Epigenetic Insulation
Review Article November 1 2025
Feasibility and Safety of Anti-PD1 First-Line Treatment of Classic Hodgkin Lymphoma: Do We See the Full Picture?
Discussion November 1 2025
The conundrum of drug development in higher-risk MDS: Lessons learned from recently failed phase 3 clinical trials
Research Article October 29 2025
The XPO7-NPAT axis represents key vulnerabilities in TP53-mutated acute myeloid leukemia
Research Article October 29 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 Cohort 3
Letter October 29 2025
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition
Research Article October 27 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML
Research Article October 27 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML
Research Article October 27 2025
A 3.3-Å cryo-EM structure of an engineered high-affinity human prothrombinase complex
Research Article October 24 2025
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial
Research Article October 23 2025
Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B
Brief Report October 21 2025
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
Research Article October 21 2025
CPX-351 in Down syndrome-associated Myeloid Leukemia: Results and Prognostic Factors from the Phase 3 ML-DS 2018 Trial
Research Article October 20 2025
The Proteostasis Network is a Therapeutic Target in Acute Myeloid Leukemia
Research Article October 17 2025
Withaferin A inhibits EBV-driven lymphomagenesis through multiple mechanisms, including EBNA1 degradation
Review Article October 17 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel
Discussion October 17 2025
MRD intervention in AML: A new therapeutic horizon
Review Article October 17 2025
Insights from Single-cell Omics: Cellular Heterogeneity as a Foundation of Clinical Outcome in Chronic Myeloid Leukemia
Review Article October 16 2025
Modulators of the Hepcidin Pathway in Polycythemia Vera and Myelofibrosis
Research Article October 16 2025
A CD22-Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignancies
Research Article October 16 2025
Human missense variants in F3 impair the initiation of blood coagulation
Research Article October 16 2025
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
Research Article October 16 2025
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials
Letter October 16 2025
NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis
Page 1 of 3

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals